Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.09.17.676793

Dietary Patterns and Gene Expression Profiles in Gastric Adenocarcinoma Patients from the Northern Region of Brazil

Abstract

BackgroundGastric adenocarcinoma (GA) remains a major public health concern worldwide, with incidence influenced by demographic, socioeconomic, and lifestyle factors. Diet is a modifiable risk factor that can shape tumor biology, potentially affecting gene expression and the tumor microenvironment. Understanding how dietary patterns correlate with molecular signatures in GA may provide insights for preventive and therapeutic strategies. MethodsThis retrospective, cross-sectional, analytical study included 60 patients diagnosed with gastric adenocarcinoma and treated at the Joao de Barros Barreto University Hospital, Para, Brazil. Structured questionnaires collected sociodemographic, lifestyle (smoking and alcohol), clinical, and dietary data. Dietary patterns were analyzed according to the Brazilian Ministry of Health guidelines. A subset of 16 patients was selected for gene expression profiling to evaluate correlations between dietary exposure and molecular alterations. ResultsThe patient cohort exhibited a predominance of males (56.7%) and older adults (>60 years), often from socioeconomically disadvantaged backgrounds. Dietary analysis revealed insufficient intake of fruits, vegetables, and legumes, alongside high consumption of ultraprocessed foods, especially sugar-sweetened beverages. Gene expression analysis identified 48 differentially expressed genes between patients with lower (LEDRF) and higher (HEDRF) dietary risk exposure. Six genes with potential biological relevance were highlighted: MAGEA3, IL6, HCAR2, NLRP4, PGA3, and CTCFL. MEFDR patients showed overexpression of MAGEA3, IL6, and HCAR2, associated with cell proliferation, inflammation, and tumor microenvironment remodeling. DiscussionThe results suggest that dietary patterns may modulate gene expression and influence the tumor microenvironment in gastric adenocarcinoma. Diets rich in ultraprocessed foods and sugar may promote a pro-inflammatory and pro-oxidant microenvironment, while consumption of fruits, vegetables, and bioactive compounds appears protective, potentially regulating epigenetic, metabolic, and immunological pathways. The study underscores the importance of integrated approaches combining nutritional intervention and molecular profiling to better understand GA progression and identify potential therapeutic targets.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Serrao, L. C., Santos da Silva, V. C., Mendes, A. K. A., Pereira, D., da Silva, J. M. C., Sousa, A. P. F. d., Mackert, D. d. O., Sa, N. N. B. d., Barra, W. F., Moreira, F. C., Assumpcao, P. P., Demachki, S., Araujo, M. d. S.. 2025-09-21. Dietary Patterns and Gene Expression Profiles in Gastric Adenocarcinoma Patients from the Northern Region of Brazil. https://doi.org/10.1101/2025.09.17.676793

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Sisyphus at the splenic flexure: sidedness in colorectal cancer

Colorectal cancer is divided into left and right to guide prognosis and therapy, yet a precise definition of left vs right sided colorectal cancer is still not fully agreed upon. The published conventions place it anywhere between the cecum and the rectosigmoid junction. The dichotomy assumes side homogeneity, i.e., that colorectal subsites within a side add limited information once the side is known. That assumption has been examined primarily through mutation prevalence, a quantity that confounds how often a driver arises with how strongly it is selected once it has. Analyzing 1,027 whole-exome and whole-genome sequenced colorectal tumors, we decomposed the prevalence of six driver groups into mutation supply and cancer effect, and asked whether a binary side label captures how each of their prevalence, mutation supply, and cancer effect vary along the colorectum. Mostly it does: the mutational input behaves as two blocks, and even the more than thirty-fold strengthening of cancer effect on BRAF V600E from sigmoid colon to cecum is adequately captured by side. But APC shows nominal evidence against side homogeneity in both prevalence and cancer effect while showing little net left-right difference, and PIK3CA H1047 rejects it in supply. The evidence for finer resolution is real but partial, and the failures do not announce themselves. We recommend additional research recording primary tumor location at the finest practicable resolution--at minimum, International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3) topography. Such well-annotated datasets would enable the left-right boundary to be a reversible analytic choice rather than an irreversible annotation.

cancer biology↗

GATA2 SUMOylation Regulates GATA2 Stability to Control Uterine Serous Carcinoma Invasion

Uterine serous carcinoma (USC) is an aggressive uterine cancer subtype that rapidly invades the uterine myometrium and is responsible for 40% of uterine cancer deaths. The molecular mechanisms that underlie this aggressive phenotype are poorly understood. We reported recently that USC tumors with low expression of the zinc-finger transcription factor GATA Binding Protein 2 (GATA2) exhibit aggressive tissue invasion, while retention of GATA2 expression is an independent predictor of 100% recurrence-free and cancer-specific survival in patients with early-stage USC. Here, we explored the mechanism of GATA2 loss in USC tumors that portend invasion. We show that GATA2 in human USC cell lines has a rapid 128-minute protein half-life due to post-translational SUMOylation, which targets GATA2 for ubiquitin-dependent proteasomal degradation. Treatment with small-molecule SUMOylation inhibitors, siRNA-mediated depletion of SUMO-2/3, or mutation of GATA2 K222 and K389 increases GATA2 levels and suppresses invasion in USC cell lines and USC tumor spheroids without impacting cell proliferation or viability. Primary USC tumors from newly diagnosed patients show markedly increased SUMO-2/3 levels and upregulation of SUMOylation pathways compared to other uterine cancer subtypes or benign endometrium, and heat-shock mediated induction of USC SUMO signaling leads to a SUMOylation-dependent reduction in GATA2 levels. Our results implicate SUMOylation as a dynamic regulator of USC GATA2 levels and support a model in which stress-related increases in SUMO activity deplete GATA2 to drive USC invasion. Our findings also raise the possibility that small-molecule SUMOylation inhibitors may benefit patients with early-stage USC disease.

cancer biology↗

SLC25A39 loss disrupts mitochondrial redox homeostasis and exposes therapeutic vulnerabilities in glioblastoma

Glioblastoma is an incurable brain tumour characterised by extensive hypoxia and phenotypic plasticity, both of which drive therapy resistance. Mitochondrial glutathione, dependent on the inner membrane carrier SLC25A39, is central to buffering the oxidative stress that hypoxia generates; its regulation and significance in glioblastoma are nonetheless unknown. We find that SLC25A39 expression is hypoxia-inducible and HIF-dependent, enriched in hypoxic tumour niches and heterogeneously expressed within and between tumours. Its loss depletes mitochondrial glutathione, causing oxidative damage to nucleic acids and lipids, mitochondrial hyperfusion, impaired respiration and a compensatory shift towards glycolysis, glutamine catabolism and serine synthesis. SLC25A39-deficient cells grow poorly, yet resist temozolomide while becoming markedly sensitive to navitoclax, an inhibitor of Bcl-2 and Bcl-xL, which increases cell killing when combined with radiation and temozolomide. In this work, we identify SLC25A39 as a metabolic vulnerability and candidate stratification marker in glioblastoma.

cancer biology↗